Phathom Pharmaceuticals, Inc.PHATNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank43
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-159.99M
↓ 12% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-143.17M
Historical baseline
PeriodValueYoY Change
TTM$-159.99M+42.3%
2024$-277.47M-65.8%
2023$-167.31M+3.0%
2022$-172.44M-27.7%
2021$-135.08M-7.5%
2020$-125.67M-18.3%
2019$-106.22M-8570.6%
2018$-1.23M-